Okamura H, Zachwieja J, Raguet S, Kelly P A
Laboratory of Molecular Endocrinology, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada.
Endocrinology. 1989 May;124(5):2499-508. doi: 10.1210/endo-124-5-2499.
Monoclonal antibodies (mAbs) were produced in BALB/c mice immunized with partially purified PRL receptors from rat liver. Two mAbs (T1 and T6) were able to completely inhibit [125I]ovine PRL ([125I]oPRL) binding to solubilized rat liver PRL receptors, while two other mAbs (U5 and U6) showed only a small effect on PRL binding, but were able to precipitate hormone-receptor complexes. Scatchard analysis of [125I]oPRL binding to rat liver microsomes in the presence of mAbs resulted in a decrease in the number of sites without changing the affinity of PRL binding by T1 and T6, whereas U5 and U6 altered neither parameter. [125I]mAb binding to rat liver microsomes was performed in the presence of various concentrations of unlabeled mAbs or oPRL to examine the interaction between mAbs. Competition of binding to the receptor was observed, respectively, between T1 and T6, U5 and U6, and U5 and E21 (a mAb to the rat liver PRL receptor previously produced). Both [125I]T1 and [125I]T6 binding were inhibited by oPRL, although not completely (80% inhibition at the higher concentrations). When [125I]T1 binding was analyzed by Scatchard analysis, two classes of binding sites to rat liver microsomes were found, of which only the number of higher affinity sites was affected by the presence of oPRL in incubation. Similar results were observed for [125I]T6 binding. [125I]mAb binding to microsomes from other tissues and species was examined. All five mAbs were able to bind to microsomes from rat tissues (liver, ovary, adrenal, prostate, and Nb2 lymphoma cells), similar to the level of [125I]oPRL binding in these tissues. The binding characteristics of [125I]T6 or [125I]U5 were essentially identical in all rat tissues examined. Although T1, U6, and E21 showed strong species specificity, there was significant binding of T6 to rabbit liver and mammary gland and of U5 to rabbit and pig mammary gland and mouse liver Competition curves of [125I]U5 binding were parallel for rat, rabbit, and mouse tissues, while [125I]T6 binding was able to distinguish PRL receptors in rabbit mammary gland from those in rat tissues. The use of 125I-labeled mAb in immunoblot analysis of the PRL receptor resulted in a marked increase in sensitivity. All mAbs detected microsomal PRL receptors in rat liver with mol wt of 84,000, 42,000 and 40,000. As little as 4 fmol receptors can be identified using this approach. Microsomal PRL receptors from rat ovary, prostate, and Nb2 cells and purified receptors from pig and rabbit mammary gland were subjected to immunoblot analysis.(ABSTRACT TRUNCATED AT 400 WORDS)
用大鼠肝脏中部分纯化的催乳素(PRL)受体免疫BALB/c小鼠,制备单克隆抗体(mAb)。两种单克隆抗体(T1和T6)能够完全抑制[125I]羊催乳素([125I]oPRL)与溶解的大鼠肝脏PRL受体的结合,而另外两种单克隆抗体(U5和U6)对PRL结合的影响较小,但能够沉淀激素-受体复合物。在单克隆抗体存在的情况下,对[125I]oPRL与大鼠肝脏微粒体的结合进行Scatchard分析,结果显示T1和T6使结合位点数量减少,但不改变PRL结合亲和力,而U5和U6对这两个参数均无影响。在不同浓度的未标记单克隆抗体或oPRL存在的情况下,进行[125I]单克隆抗体与大鼠肝脏微粒体的结合实验,以检测单克隆抗体之间的相互作用。分别观察到T1与T6、U5与U6以及U5与E21(先前制备的针对大鼠肝脏PRL受体的单克隆抗体)之间存在与受体结合的竞争。oPRL可抑制[125I]T1和[125I]T6的结合,尽管不完全抑制(高浓度时抑制80%)。通过Scatchard分析[125I]T1的结合情况,发现大鼠肝脏微粒体存在两类结合位点,孵育时oPRL的存在仅影响高亲和力位点的数量。[125I]T6的结合也观察到类似结果。检测了[125I]单克隆抗体与其他组织和物种微粒体的结合。所有五种单克隆抗体均能与大鼠组织(肝脏、卵巢、肾上腺、前列腺和Nb2淋巴瘤细胞)的微粒体结合,其结合水平与这些组织中[12�I]oPRL的结合水平相似。在所有检测的大鼠组织中,[125I]T6或[125I]U5的结合特性基本相同。尽管T1、U6和E21表现出很强的物种特异性,但T6能与兔肝脏和乳腺显著结合,U5能与兔和猪的乳腺以及小鼠肝脏结合。[125I]U5与大鼠、兔和小鼠组织的结合竞争曲线平行,而[12�I]T6的结合能够区分兔乳腺中的PRL受体与大鼠组织中的PRL受体。在PRL受体的免疫印迹分析中使用125I标记的单克隆抗体,可显著提高灵敏度。所有单克隆抗体均能检测到大鼠肝脏微粒体中分子量为84000、42000和40000的PRL受体。使用这种方法可鉴定低至4 fmol的受体。对大鼠卵巢、前列腺和Nb2细胞的微粒体PRL受体以及猪和兔乳腺的纯化受体进行了免疫印迹分析。(摘要截断于400字)